Cargando…
A Comparative Study on the Efficacy and Safety of Dose Escalation of Luseogliflozin in Type 2 Diabetes Mellitus Patients With Poor Glycemic Control
Objective In this study, we aimed to assess the safety and efficacy of the dose escalation of luseogliflozin (LUSEO) in type 2 diabetes mellitus (T2DM) patients with poor glycemic control. To that end, we compared two groups assigned to two different doses of luseogliflozin (LUSEO) for 12 weeks. Met...
Autores principales: | Arao, Tadashi, Okada, Yosuke, Kurozumi, Akira, Tanaka, Yoshiya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950847/ https://www.ncbi.nlm.nih.gov/pubmed/36846645 http://dx.doi.org/10.7759/cureus.35393 |
Ejemplares similares
-
Luseogliflozin Additively Enhances the Glucose-Lowering Effect of an Incretin Modulator in a High-Carbohydrate Diet
por: Lee, Gendai
Publicado: (2022) -
Excess Visceral Adipose Tissue Worsens the Vascular Endothelial Function in Patients with Type 2 Diabetes Mellitus
por: Kurozumi, Akira, et al.
Publicado: (2016) -
The Frequency of Poor Sleep Quality in Patients With Diabetes Mellitus and Its Association With Glycemic Control
por: Farooque, Rabia, et al.
Publicado: (2020) -
Efficacy of α‐glucosidase inhibitors combined with dipeptidyl‐peptidase‐4 inhibitor (alogliptin) for glucose fluctuation in patients with type 2 diabetes mellitus by continuous glucose monitoring
por: Kurozumi, Akira, et al.
Publicado: (2013) -
Glycemic Control During Enteral Tube Feeding in Patients with Diabetes Mellitus
por: Sarfo-Adu, Benedicta N, et al.
Publicado: (2019)